NCT04295837

Brief Summary

Background: Persons living with chronic conditions often have decreased ability to perform Activities of Daily Living (ADL) tasks, stressing a need to develop and evaluate intervention programs addressing decreased ADL ability. Guided by the British Medical Research Council's guidance (MRC) on how to develop and evaluate complex interventions, the program "A Better everyday LifE" (ABLE), a home-based intervention program, was developed and feasibility tested. The current phase concerns a full-scale evaluation of the ABLE program including evaluation of effectiveness, processes and cost-effectiveness. Material and Methods: The design involves a randomized controlled trial, initiated with an internal pilot. The study will include eighty (n=80) home dwelling persons living with chronic conditions, experiencing problems performing ADL. Participants are randomized to either intervention (ABLE) or control (usual care). Co-primary outcomes are self-reported ADL ability measured using ADL-Questionnaire (ADL-Q) and observed ADL motor ability measured using Assessment of Motor and Process Skills (AMPS). Secondary outcomes are perceived satisfaction with ADL task performance measured using ADL-Q; observed ADL process ability measured using AMPS; and Goal Attainment measured using Goal-Attainment-Scaling (GAS). Data is collected at baseline, post intervention and six months after baseline. Process evaluation data are collected using registration forms and semi-structured qualitative interviews. The economic evaluation will be performed from a health care sector perspective with 6 months follow-up. Costs will be estimated based on micro costing and national registries. Effects will be Quality Adjusted Life Years and changes in AMPS ADL ability.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
78

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Dec 2019

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

December 5, 2019

Completed
4 days until next milestone

Study Start

First participant enrolled

December 9, 2019

Completed
3 months until next milestone

First Posted

Study publicly available on registry

March 5, 2020

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 20, 2021

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 21, 2021

Completed
Last Updated

April 28, 2022

Status Verified

April 1, 2022

Enrollment Period

1.6 years

First QC Date

December 5, 2019

Last Update Submit

April 27, 2022

Conditions

Outcome Measures

Primary Outcomes (2)

  • Change in observed ADL motor ability - with the Assessment of Motor and Process Skills (AMPS)

    Observation-based measure of ADL ability - motor

    Week 10

  • Change in self-reported ADL ability - with the ADL-Interview (ADL-I)

    Self-report based on interview addressing perceived ability to perform ADL tasks. Linear measures of ADL ability will be generated using Rasch measurement models. Higher scores mean more ADL ability.

    Week 10

Secondary Outcomes (6)

  • Change in observed ADL process ability - with the Assessment of Motor and Process skills (AMPS)

    Week 10

  • Change in observed ADL process ability - with the Assessment of Motor and Process skills (AMPS)

    Week 27

  • Change in observed ADL motor ability - with the Assessment of Motor and Process skills (AMPS)

    Week 27

  • Change in self-reported satisfaction with ADL ability - with the ADL-Interview (ADL-IS)

    Week 10

  • Change in self-reported satisfaction with ADL ability - with the ADL-Interview (ADL-IS)

    Week 27

  • +1 more secondary outcomes

Other Outcomes (10)

  • Occupational Balance Questionnaire (OBQ11)

    Week 10

  • Occupational Balance Questionnaire (OBQ11)

    Week 27

  • EuroQoL 5 dimensions (EQ-5D)

    Week 10

  • +7 more other outcomes

Study Arms (2)

ABLE - A Better everday LifE

EXPERIMENTAL

A home-based occupational therapy intervention addressing ADL task performance issues among persons living with chronic conditions. The ABLE intervention is occupation-focused and -based, and follows a structured process of assessment, goalsetting, intervention and evaluation.

Other: ABLE

Usual care

ACTIVE COMPARATOR

Community-based occupational therapy addressing ADL task performance issues among persons living with chronic conditions

Other: Usual Care

Interventions

ABLEOTHER

Home-based occupational therapy compensatory programme addressing activities of daily living

ABLE - A Better everday LifE

Standard occupational therapy

Usual care

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ one year since medical diagnosed with one or more chronic conditions
  • Perceive problems performing ADL tasks
  • ≥ 18 years of age
  • Lives in own home
  • Motivated and ready for making changes in ADL performance
  • Motivated and ready to participate in program
  • Communicates independently and relevant
  • Able to understand and relevantly answer a questionnaire

You may not qualify if:

  • PADL problems with acute need for help (if the client does not already receive help from home carer
  • Known substance abuse
  • Mental illness, and/or other acute illness effecting ADL task performance
  • Communication barriers (e.g. severe cognitive deficits; and barriers that prevents receiving information on study)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

The Parker Research Institute, Department of Rheumatology, Copenhagen University Hospital, Bispebjerg and Frederiksberg

Frederiksberg, 2000, Denmark

Location

Related Publications (2)

  • Hagelskjaer V, Nielsen KT, von Bulow C, Oestergaard LG, Graff M, Waehrens EE. Evaluating a complex intervention addressing ability to perform activities of daily living among persons with chronic conditions: study protocol for a randomised controlled trial (ABLE). BMJ Open. 2021 Nov 26;11(11):e051722. doi: 10.1136/bmjopen-2021-051722.

  • Hagelskjaer V, Nielsen KT, von Bulow C, Graff M, Waehrens EE. Occupational therapy addressing the ability to perform activities of daily living among persons living with chronic conditions: a randomised controlled pilot study of ABLE 2.0. Pilot Feasibility Stud. 2021 Jun 11;7(1):122. doi: 10.1186/s40814-021-00861-9.

MeSH Terms

Conditions

Multiple Chronic Conditions

Condition Hierarchy (Ancestors)

Chronic DiseaseDisease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Eva E Wæhrens, PhD

    The Parker Research Institute, Bispebjerg and Frederiksberg Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
TRIPLE
Who Masked
PARTICIPANT, INVESTIGATOR, OUTCOMES ASSESSOR
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Senior researcher, associate professor

Study Record Dates

First Submitted

December 5, 2019

First Posted

March 5, 2020

Study Start

December 9, 2019

Primary Completion

July 20, 2021

Study Completion

October 21, 2021

Last Updated

April 28, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will not share

Locations